A class-action lawsuit against Canadian cannabis operator Sundial Growers hurt the sector Monday, but stocks turned around in afternoon trading Tuesday.
Cannabis retailer MedMen is snuffing out its planned $682 million all-stock deal to buy marijuana producer and distributor PharmaCann, and is also replacing its financial chief.
Cannabis license owner and retailer MedMen Enterprises is snuffing out its planned $682 million all-stock deal to buy marijuana producer and distributor PharmaCann -- less than three months after receiving a second round of capital from private-equity firm Gotham Green Partners.
A report says Sundial is the subject of a class action lawsuit for failing to disclose that a customer returned 554 kilograms of cannabis because it contained mold and bits of rubber gloves.
